ADVERTISEMENT

Man’s best friend, fatal in the end

Cleveland Clinic Journal of Medicine. 2017 February;84(2):146-150 | 10.3949/ccjm.84a.16061
Author and Disclosure Information

CASE CONTINUED: TRANSFER TO ICU

The patient was empirically started on vancomycin and ceftriaxone and transferred to the intensive care unit. She required intubation for airway protection. She became hypotensive despite receiving intravenous fluids and multiple vasopressors. She continued to rapidly decline and developed lactic acidosis, which resulted in a severe anion gap metabolic acidosis with respiratory compensation.  Her course was further complicated by disseminated intravascular coagulation, acute kidney failure, and ischemic hepatitis (“shock liver”) (Table 2).

CAUSES OF SEPSIS IN ASPLENIC PATIENTS

3. The patient’s septic shock is likely the result of which bacterial pathogen?

  • S pneumoniae
  • H influenzae
  • C canimorsus
  • N meningitidis

Encapsulated organisms including S pneumoniae, H influenzae, and N meningitidis account for almost 70% of infections in postsplenectomy patients, including those with overwhelming postsplenectomy infection.6S pneumoniae is the most common culprit. However, the patient’s history of a recent dog bite suggests that the most likely cause was C canimorsus.

C canimorsus is a gram-negative bacillus commonly associated with exposure to dogs or cats through saliva, scratches, or bites.7,8 Even a seemingly small, benign-appearing wound, as seen in this case, can be a portal of entry for this organism. About 84 cases leading to fulminant sepsis were reported in the United States from 1990 to 2014.9 Patients infected with this organism can progress to fulminant sepsis with multiorgan failure with disseminated intravascular coagulation, anuria, and hypotension.10–12

CASE CONCLUDED

The patient died 40 hours after admission. Her blood cultures grew a slow-growing gram-negative rod within 2 days, subsequently identified as C canimorsus.

4. What is the best strategy for prevention of sepsis in an asplenic patient?

  • Vaccinate against S pneumoniae (with PCV13 and PPSV23), H influenzae type b, and N meningitidis
  • Prescribe antibiotics that the patient can take in case of fever
  • Both of the above
  • Prescribe lifelong daily antibiotic prophylaxis
  • All of the above

Asplenic patients should receive pneumococcal, H influenzae type b, and meningococcal vaccines.13 Invasive bacterial infections, particularly with encapsulated organisms, occur 10 to 50 times more often in this population than in a healthy population and can be fatal.13 These vaccines have been shown to reduce the rate of life-threatening infections. Patients should receive the vaccines at least 2 weeks before an elective splenectomy or 2 weeks after a nonelective splenectomy.2

For the pneumococcal vaccines, PCV13 should be given first, followed by PPSV23 at least 8 weeks later. If the patient has already received PCV13, PPSV23 should be given at least 2 weeks after splenectomy. A second dose of PPSV23 should be given 5 years later.

The H influenzae type b vaccine should be administered if not already given.

For the meningococcal vaccine, the two-dose series should be administered with an interval of 8 to 12 weeks between doses. A booster meningococcal dose should be given every 5 years.

The patient should also receive the flu vaccine annually.2,14

Patients should also be given antibiotics (typically an antibiotic with activity against S pneumoniae, such as amoxicillin or levofloxacin) to carry with them. They should be told to take them if fever or chills develop and they cannot see a physician within 2 hours.2

Daily antibiotic prophylaxis with penicillin is typically given to patients younger than age 5, as studies have shown benefit in reducing pneumococcal sepsis. In adults, some experts recommend daily antibiotic prophylaxis for 1 year after splenectomy.2 However, there is a lack of data and expert consensus to recommend lifelong daily antibiotic prophylaxis for all asplenic patients. Thus, it is not recommended in adults unless the patient is immunocompromised or is a survivor of pneumococcal sepsis.4

KEY POINTS

  • In an asplenic patient, fever can be an early sign of sepsis, which can have a rapid and fulminant course.
  • Asplenic patients are particularly susceptible to infection by encapsulated organisms such as S pneumoniae, H influenzae, N meningitidis, and C canimorsus due to impaired immunity.
  • If an asplenic patient has been exposed to a dog bite, scratch, or saliva, one should suspect C canimorsus.
  • Asplenic patients who present with fever should be treated immediately with intravenous vancomycin and ceftriaxone without delay for laboratory tests or imaging.
  • To help prevent fulminant sepsis, asplenic patients should receive vaccines (pneumococcal, meningococcal, and H influenzae type b) as well as a prescription for antibiotics (levofloxacin) to be used if they develop fever and cannot see a physician within 2 hours.